Basics Quanterix Corporation Quanterix Corp is a life science company. The company digitizing biomarker analysis with the goal of advancing the science of precision health. IPO Date: December 7, 2017 Sector: Healthcare Industry: Biotech Market Cap: $211.42M Activated in VL: True Average Daily Range Avg Daily Range: $0.76 | 3.07% Avg Daily Range (30 D): $0.13 | 2.47% Avg Daily Range (90 D): $0.20 | 3.58% Institutional Daily Volume Avg Daily Volume: .29M Avg Daily Volume (30 D): .65M Avg Daily Volume (90 D): .67M Trade Size Avg Trade Size (Sh.): 69 Avg Trade Size (Sh.) (30 D): 84 Avg Trade Size (Sh.) (90 D): 87 Institutional Trades Total Inst.Trades: 1,275 Avg Inst. Trade: $1.33M Avg Inst. Trade (30 D): $.64M Avg Inst. Trade (90 D): $.78M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.26M Avg Closing Trade (30 D): $.61M Avg Closing Trade (90 D): $.85M Avg Closing Volume: 46.58K     News May 23, 2025 @ 1:10 PM New Data and Deal Flow Signal a Turning Point for ... Source: Prnewswire Apr 28, 2025 @ 10:00 PM $HAREHOLDER ALERT: The M&A Class Action Firm Urges... Source: Monteverde & Associates Pc Apr 2, 2025 @ 10:50 PM $TOCKHOLDER ALERT: The M&A Class Action Firm Urges... Source: Monteverde & Associates Pc Feb 18, 2025 @ 8:30 PM Quanterix Corporation Announcement: If You Have Su... Source: N/A Feb 14, 2025 @ 11:30 PM $TOCKHOLDER ALERT: The M&A Class Action Firm Conti... Source: Monteverde & Associates Pc Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.82 $-.77 $-.53 Diluted EPS $-1.82 $-.77 $-.53 Revenue $ 125.78M $ 24.48M $ 30.33M Gross Profit $ 70.04M $ 11.3M $ 16.42M Net Income / Loss $ -70.5M $ -30.01M $ -20.5M Operating Income / Loss $ -89.98M $ -37.1M $ -26.37M Cost of Revenue $ 55.75M $ 13.18M $ 13.92M Net Cash Flow $ 85.93M $ 56.39M $ 19.83M PE Ratio